INS and choreatic disease: In particular, a SIRT1 inhibitor EX527 significantly prevented BCH-induced increased phosphorylation of insulin signaling molecules (Fig. 2g), suggesting that SIRT1 activation was involved in BCH-induced improvement in insulin resistance in HF/HFr-fed mouse hepatocytes.